최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Antiviral research, v.146, 2017년, pp.112 - 120
Zivcec, Marko (Corresponding author.) , Guerrero, Lisa I.W. , Albariño, César G. , Bergeron, Éric , Nichol, Stuart T. , Spiropoulou, Christina F.
Abstract Despite the serious public health impact of Crimean-Congo hemorrhagic fever (CCHF), the efficacy of antivirals targeting the causative agent, CCHF virus (CCHFV), remains debatable. Neutralizing monoclonal antibodies (MAbs) targeting the CCHFV glycoprotein Gc have been reported to protect m...
Antivir. Res. Bente 100 159 2013 10.1016/j.antiviral.2013.07.006 Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity
PLoS Pathog. Bergeron 11 e1004879 2015 10.1371/journal.ppat.1004879 Recovery of recombinant Crimean Congo hemorrhagic fever virus reveals a function for non-structural glycoproteins cleavage by furin
J. Virol. Bertolotti-Ciarlet 79 6152 2005 10.1128/JVI.79.10.6152-6161.2005 Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins
PLoS One Buttigieg 9 2014 10.1371/journal.pone.0091516 A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model
PLoS Negl. Trop. Dis. Canakoglu 1 2015 Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine
Antivir. Res. Cross 133 218 2016 10.1016/j.antiviral.2016.08.012 Treatment of Lassa virus infection in outbred Guinea pigs with first-in-class human monoclonal antibodies
PLoS One Dowall 11 1 2016 10.1371/journal.pone.0156637 Protective effects of a modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses
Vector Borne Zoonotic Dis. Duygu 12 812 2012 10.1089/vbz.2011.0694 Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Curr. Opin. Virol. Ergonul 2 215 2012 10.1016/j.coviro.2012.03.001 Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries
Virology Erickson 361 348 2007 10.1016/j.virol.2006.11.023 N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport
PLoS One Estrada-Peña 10 1 2015 10.1371/journal.pone.0125760 The impact of climate trends on a tick affecting public health: a retrospective modeling approach for Hyalomma marginatum (ixodidae)
Cell Flyak 164 392 2016 10.1016/j.cell.2015.12.022 Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection
Vector Borne Zoonotic Dis. Gargili 11 747 2011 10.1089/vbz.2010.0030 Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans
Sci. Transl. Med. Geisbert 6 2014 10.1126/scitranslmed.3008929 Therapeutic treatment of nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody
Epidemiol. Infect. Goedhals 142 1952 2014 10.1017/S0950268814000818 Next-generation sequencing of southern African Crimean-Congo haemorrhagic fever virus isolates reveals a high frequency of M segment reassortment
J. Virol. Hinkula 2017 10.1128/JVI.02076-16 Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and/or virus-like particles induces protection and survival in challenged mice
J. Clin. Virol. Koksal 47 65 2010 10.1016/j.jcv.2009.11.007 The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey
Vector-Borne Zoonotic Dis. Kortekaas 15 759 2015 10.1089/vbz.2015.1855 Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice
Jpn. J. Infect. Dis. Kubar 64 439 2011 10.7883/yoken.64.439 Prompt administration of Crimean-Congo hemorrhagic fever ( CCHF ) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by Reverse Transcriptase-PCR
PLoS Pathog. Pal 9 2013 10.1371/journal.ppat.1003312 Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
Emerg. Infect. Dis. Papa 20 288 2014 10.3201/eid2002.130690 Crimean-Congo hemorrhagic fever virus, Greece
J. Med. Virol. Papa 88 21 2016 10.1002/jmv.24312 Cytokines as biomarkers of Crimean-Congo hemorrhagic fever
PLoS Negl. Trop. Dis. Qiu 6 31 2012 10.1371/journal.pntd.0001575 Ebola GP-specific monoclonal antibodies protect mice and Guinea pigs from lethal Ebola virus infection
Nature Qiu 514 47 2014 10.1038/nature13777 Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
BMC Infect. Dis. Soares-Weiser 10 207 2010 10.1186/1471-2334-10-207 Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis
J. Infect. Dis. Spengler 2017 10.1093/infdis/jix215 Crimean-Congo hemorrhagic fever in humanized mice reveals Glial cells as primary targets of neurological infection
South Afr. Med. J. Van Eeden 68 718 1985 A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital Part II. Management of patients
Science Wec 354 12598 2016 10.1126/science.aag3267 A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses
Curr. Top. Microbiol. Immunol. Wu 317 103 2008 Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab
Proc. Natl. Acad. Sci. U. S. A. Zeitlin 113 4458 2016 10.1073/pnas.1600996113 Monoclonal antibody therapy for Junin virus infection
PLoS Negl. Trop. Dis. Zivcec 9 2015 10.1371/journal.pntd.0004259 Assessment of inhibitors of pathogenic Crimean-Congo hemorrhagic fever virus strains using virus-like particles
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.